The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial
Bose, K.
Methods and Findings in Experimental and Clinical Pharmacology 21(3): 209-213
1999
ISSN/ISBN: 0379-0355 PMID: 10389124 Document Number: 501067
A randomized, double-blind, clinical trial was undertaken to assess the activity of eperisone hydrochloride (50 mg t.i.d.), a commonly used muscle relaxant, as a treatment for cervical spondylosis in 157 patients. The results showed a clear benefit of eperisone treatment with regard to pain in the nuchal region, back pain, pain in arms and shoulders, stiffness and other symptoms of cervical spondylosis, while the tolerability of the treatment was optimal.
Document emailed within 1 workday
Related Documents
Bednarz, B.ła.; Jaxa-Chamiec, T.; Maciejewski, P.ł; Szpajer, M.ł; Janik, K.; Gniot, J.; Kawka-Urbanek, T.; Drozdowska, D.; Gessek, J.; Laskowski, H. 2005: Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMi pilot trial Kardiologia Polska 62(5): 421-427Morozova, M.A.; Beniashvili, A.G.; Lepilkina, T.A.; Rupchev, G.E. 2012: Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission Psychiatria Danubina 24(2): 159-166
Trnavský, K.; Fischer, M.; Vögtle-Junkert, U.; Schreyger, F. 2004: Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study Journal of Rheumatology 31(3): 565-572
Bieber, T.; Chosidow, O.; Bodsworth, N.; Tyring, S.; Hercogova, J.; Bloch, M.; Davis, M.; Lewis, M.; Boutolleau, D.; Attali, P.; Bisshop, F.R.; Bloch, M.T.; Bodworth, N.J.; Aster, V.; Asterova, J.; Hercogova, J.; Klimesova, R.; Krajsova, I.; Ben Slama, L.; Cambazard, F.; Chosidow, O.; Dubertret, L.; Granel, F.; Humbert, P.; Ortonne, J.P.; Rostain, G.; Ruer-Mulard, M.; Vaillant, L.; Beiber, T.; Degen, A.J.; Dörzapf, O.; von Hake, G.; Miller, A.; Naudts, I.; Steinert, M.; Stockfleth, E.; Weihe, J.; Wunderlich, U.; Jasieniak-Pinis, G.; Kazina, M.; Pawlaczyk-Strugala, E.; Placek, W.; Petryka, R.; Romanowski, L.; Dixon, C.J.; Lewis, M.; Sharma, R.; Archuleta, M.; Baker, D.A.; Cady, R.K.; Conant, M.A.; Crump, W.L.; Davis, M.G.; Dunlap, F.E.; Lee 2014: Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial Journal of Drugs in Dermatology: Jdd 13(7): 791-798
Cheechareoan, S.; Pathanawiriyasirikul, T.; Manmee, C.; Janpol, K. 2016: Efficacy of Plai Cream in Adult Patients with Muscle Strain: a Randomized, Double-Blind, Placebo-Controlled Trial Journal of the Medical Association of Thailand 99(Suppl 2): S147-S152
Glogau, R.; Blitzer, A.; Brandt, F.; Kane, M.; Monheit, G.D.; Waugh, J.M. 2012: Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type a topical gel for the treatment of moderate-to-severe lateral canthal lines Journal of Drugs in Dermatology: Jdd 11(1): 38-45
Arora, S.; Katkov, W.; Cooley, J.; Kemp, J.A.; Johnston, D.E.; Schapiro, R.H.; Podolsky, D. 1999: Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial Hepato-Gastroenterology 46(27): 1724-1729
Kondo, H.; Abe, T.; Hashimoto, H.; Uchida, S.; Irimajiri, S.; Hara, M.; Sugawara, S. 2004: Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study Journal of Rheumatology 31(2): 243-251
Kongkanand, A.; Ratana-Olarn, K.; Ruangdilokrat, S.; Tantiwong, A. 2003: The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study Journal of the Medical Association of Thailand 86(3): 195-205
Plewig, G.; Cunliffe, W.J.; Binder, N.; Höschen, K. 2009: Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase IIi trial Contraception 80(1): 25-33
Bobat, R.; Coovadia, H.; Stephen, C.; Naidoo, K.L.; McKerrow, N.; Black, R.E.; Moss, W.J. 2005: Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial Lancet 366(9500): 1862-1867
Weiler, J.M.; Gellhaus, M.; Donnelly, A.; Weiler, K. 1990: Randomized, double-blind, parallel groups, placebo-controlled study of efficacy and safety of Rynatan in the treatment of allergic rhinitis using an acute model Annals of Allergy 64(1): 63-67
Chang, A.L.S.; Alora-Palli, M.; Lima, X.T.; Chang, T.C.; Cheng, C.; Chung, C.M.; Amir, O.; Kimball, A.B. 2012: A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks Journal of Drugs in Dermatology: Jdd 11(3): 333-339
Maki, M.; Kobayashi, T.; Terao, T.; Ikenoue, T.; Satoh, K.; Nakabayashi, M.; Sagara, Y.; Kajiwara, Y.; Urata, M. 2000: Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group Thrombosis and Haemostasis 84(4): 583-590
Mease, P.J.; Russell, I.J.; Arnold, L.M.; Florian, H.; Young, J.P.; Martin, S.A.; Sharma, U. 2008: A randomized, double-blind, placebo-controlled, phase IIi trial of pregabalin in the treatment of patients with fibromyalgia Journal of Rheumatology 35(3): 502-514
Appelberg, B.G.; Syvälahti, E.K.; Koskinen, T.E.; Mehtonen, O.P.; Muhonen, T.T.; Naukkarinen, H.H. 2001: Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study Journal of Clinical Psychiatry 62(6): 448-452
Kwanchuay, P.; Petchnumsin, T.; Yiemsiri, P.; Pasuk, N.; Srikanok, W.; Hathaiareerug, C. 2015: Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study Journal of the Medical Association of Thailand 98(12): 1231-1236
Chen, W-Hong.; Kaul, U.; Leung, S-Kin.; Lau, Y-Kong.; Tan, H-Cheem.; Leung, A.Wai-Suen.; Lee, M.Kang-Yin.; Li, S-Kin.; Ng, W.; Lee, P-Yin.; Lam, K-Fai.; Tse, H-Fat.; Lau, C-Pak. 2005: A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial Journal of Invasive Cardiology 17(10): 534-538
Coovadia, H.M.; Brown, E.R.; Fowler, M.Glenn.; Chipato, T.; Moodley, D.; Manji, K.; Musoke, P.; Stranix-Chibanda, L.; Chetty, V.; Fawzi, W.; Nakabiito, C.; Msweli, L.; Kisenge, R.; Guay, L.; Mwatha, A.; Lynn, D.J.; Eshleman, S.H.; Richardson, P.; George, K.; Andrew, P.; Mofenson, L.M.; Zwerski, S.; Maldonado, Y. 2012: Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial Lancet 379(9812): 221-228
Mil'chakova, L.E.; Gekht, A.B. 2010: Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(3 Suppl 2: 39-43